INS and metabolic dysfunction-associated steatohepatitis: In addition, salidroside can effectively prevent high-fat/high-cholesterol-diet-induced NASH (non-alcoholic steatohepatitis) progression by regulating glucose metabolism dysregulation [34,35], insulin resistance, lipid accumulation, inflammation, and fibrosis.